chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 16 year old female patient with no pertinent medical history and no drug reactions/allergies, who on an unknown date was vaccinated IM with a dose (which dose in the series was unknown) of GARDASIL (lot number and dose not reported). There was no concomitant medication. It was reported that the patient experienced tonic-clonic seizure in both arms after being administered with a dose of GARDASIL. The event occurred in the physician's office. No lab diagnostics studies were performed. On the same day the tonic-clonic seizure in both arms occurred, the patient recovered. Upon internal review, the tonic-clonic seizure in both arms was determined to be an other important medical event. This is one of several reports received from the same source. Additional information has been requested.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Additional Details: pt had first dose of shingrix on 9/2/22 and signed up for a 2nd dose on 10/7/22. dose was given too early. Guideline is 2 months from first dose. pt got hives on face and upper part of body. md had asked pt to use benadryl and calamine lotion
Severe vomiting, body aches, severe H/A, chills 3 hours after vaccine, severe sx x6 hrs.
Woke up in the middle of the night with sharp chest pain. Went to the ER and was diagnosed with costochondritis. I recovered within a few days just medicating with advil and tylenol. I am reporting this incident because I have seen reports from the CDC about cases of myocondritis occuring after vaccination, and symptoms very similar to what I experienced.   https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html
Patient was 5 days early for vaccine. States she is aware but wishes to proceed. Discussed CDC recommendations. First dose 04/25/2021.
Extreme Gastro intentional Nausea..... swelling whelp at injection site  with clear blisters and white on day 10....  larger red area still growing with additional blisters..... swelling in face with rash as well as throat.... burning feeling I. Throat.....hot spots on upper chest..... day 17 swelling knots on top of head not side or back about 6
Case number PHEH2015US023876 is an initial spontaneous report received from a health care professional on 13 Nov 2015. This report refers to a 13 year old male patient. Medical history and concomitant medication were not reported. The patient was vaccinated with FLUCELVAX (batch number: 173989) intramuscularly at a dose of 0.5 ml on 11 Nov 2015. No adverse event was reported following this medication error (drug administered to patient of inappropriate age).
APPROX 5 MINUTES AFTER INNOCULATION THE PATIENTS EYES ROLLED IN THE BACK OF HER HEAD AND SHE BEGAN SEIZING AND I CAUGHT HER BEFORE SHE HIT THE GROUND
The patient did not report any adverse events after being vaccinated.; The patient received an improperly stored vaccine M-M-R on unspecified date between 18-MAR-2020 to 24-MAR-2020.; This spontaneous report has been received from a physician, regarding to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported.  On an unspecified day in March 2020 (also reported as "between 18-MAR-2020 and 24-MAR-2020"), the patient was vaccinated with an improperly stored Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) administered subcutaneously (SC) as prophylaxis (dose, frequency and expiration date were not reported); the lot number S027461 was an invalid lot number for Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live. In addition, the physician stated that it was determined from the stability data, that the suspect vaccine was stable, and that the patient did not report any adverse events after being vaccinated. Additional information was not expected.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2003USA006671: US-009507513-2004USA001738: US-009507513-2004USA001739: US-009507513-2004USA001740:
Information has been received from a pharmacist concerning a 79 year old female patient, who on 20-FEB-2009, was vaccinated with ZOSTAVAX (Merck), 0.65ml, subcutaneously in arm. In the week of 23-FEB-2009, the patient experienced stiffness in her neck/tight muscles in her neck a few days after receiving ZOSTAVAX (Merck). The patient called the pharmacy to seek for medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.
nausea; headache; pain all over; chills; legs and arms weak; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (legs and arms weak), NAUSEA (nausea), HEADACHE (headache), PAIN (pain all over) and CHILLS (chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Cholesterol, Sarcoidosis, Diabetes, Autoimmune disorder NOS and Asthma.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced MUSCULAR WEAKNESS (legs and arms weak), HEADACHE (headache), PAIN (pain all over) and CHILLS (chills). On an unknown date, the patient experienced NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Pain, at an unspecified dose and frequency. At the time of the report, MUSCULAR WEAKNESS (legs and arms weak), NAUSEA (nausea), HEADACHE (headache), PAIN (pain all over) and CHILLS (chills) outcome was unknown.      Concomitant medications reported were blood pressure medication, high cholesterol medication, sarcoid medication, diabetes medication, autoimmune disease medication, inhaler for asthma.
PT HAS PHN ADVERSE EFFECTS -POST HERPETIC NEURALGIA, INSOMINA, PAIN ,ANKLE TWITCHING, TROUBLE SLEEPING, STATES HIS NEUROLOGICAL SYMPTOMS ARE BEYOUND JUST NORMAL SHINGLES
I had my vaccination on 10/17/2022. On 01/06/2023 I had symptoms to include congestion coughing and fever. The symptoms started to get worse with a sore throat headache and vertigo. I tested COVID-19 positive on 01/12/2023. I was informed to take prednisone ear drops nasal spray and TYLENOL. I presently still feel quite ill on 01/18/2023.
Within weeks began having constant chronic headaches and dizziness, these persisted for 7 months. Stroke occurred causing right side to be partially paralyised. headaches still persist two months following stroke.
Site: Itching at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild
Mother reports won't walk or let you move her legs. Low grade temps since yesterday. Poor appetite, is drinking and voiding. Fine when sitting still. Received flu, MMR and QUADRECEL 9/21/18. Of note, had similar episode in the spring when dad had influenza. Seen at express care and DX with toxic synovitis. SX resolved. No known injury. Temp 100.8.
1 of 2 pts who recvd DTaP/OPV devel generalized urticaria; the reporting allergist who is also the mom of child reports that pt devel lesions on face (erythema multiforme);  resolved 24 hrs later; tx w/single dose DPH;
FACIAL SWELLING; STIFFNESS; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced facial swelling, and stiffness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the facial swelling and stiffness was not reported. This report was non-serious.
On Tuesday, seven days after receiving the second dose of Shingrix, I began to notice a rash developing on my upper chest in the morning.  By Tuesday evening, I noticed that the rash had spread significantly on my chest, shoulders and back.  I went to Urgent care at 830PM.  I was told that it appeared to be an allergic response and was told to take Claritin and Benedryl and to use Cortisone cream.    By Wednesday the rash was significantly worse and extremely itchy and painful in some spots.  My PCP was unavailable, but I was able to see another doctor.  She said to continue taking the same meds, but to add Zyrtec 5mg/day.  She advised me to see an Allergist for allergy testing as soon as possible.  By Thursday morning, the rash was worse and began to spread down my legs (a few spots).  Also, my right eyelid was noticeably swollen.  Out of concern for my eye, I returned to Urgent care and was evaluated.  The doctors said that eyelid swelling was common with allergies.  On Friday, I saw a dermatologist.  He examined me and said the he was certain this was a vaccine allergic reaction and that it must have been in response to the Shingrix vaccine.  As if today, the rash is approximately 75% resolved and the eyelid swelling is approximately 50% resolved.
Confirmed Breakthrough 1st Dose - 3/19/2021 - Lot er8727 2nd Dose - 4/12/2021 - Lot er8733 3rd Dose - 12/20/2021 - Lot fj8757
I started to feel pressure in my chest and pain in between the shoulder blades. I brushed it off fora few months, because I thought it was caused by stress and anxiety. The pain then started to radiate to my neck, down to both shoulders, and down to the right arm in February 2023. My right hand also started to go numb at this point. The pain was so intense that I was in tears. Not only that, but my blood pressure was fluctuating from one extreme to another. At one point, it was 210/109 with a pulse of about 121. I would then become run down, and my blood pressure would dip to 117/68 or 117/72, Whenever this happened, I felt extremely fatigued. I saw my PCP on 2/8/2023. My PCP prescribed me clonidine (0.1 mg), which I was instructed to take four times a day as needed for blood pressure spikes. The clonidine made me very lethargic. On or about 2/27/2023, I called 911, and I was evaluated by paramedics. Although I was not having a heart attack at that time, they did detect an irregular heartbeat, and they suggested that I go to the ER. While I was at the ER, I underwent an EKG and triage. I was told that I would have to wait ten hours to be seen, so I just left, because I was already under a great deal of stress. When I went to the cardiologist later on, he told me that leaving early was a good idea, because the stress could have actually led to a heart attack. I asked my PCP to refer me to a cardiologist, and I saw the cardiologist within a week. I saw the cardiologist for the first time on 3/13/2023. On that day, the cardiologist took me off of clonidine, because he said that it was basically a Band-Aid fix for a larger problem. He then prescribed me amlodipine (5mg), which I am to take once in the morning every day. At bedtime, I am to follow it up with losartan (50mg). I have also been instructed to take my blood pressure three times a day until I see him again. The cardiologist would like me to undergo a chemical stress test; he didn't want to have me undergo a physical stress test, because he wasn't sure my body could handle it. He would also like me to take a coronary calcium scan. Since following the cardiologist's orders, I have been feeling better. I still have chest pains sometimes, though, so I am concerned about that. I'm wondering if there is another issue we don't know about. Last year, my brother died of a massive heart attack, so I wonder if there could a genetic component.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. In approximately 2013, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. In or about April 2016, the patient was treated by a physician for the onset of a severe rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcomes of the events were unknown at the time of reporting. Causality assessment was related. Additional information has been requested.
Periodic heart breaking; Shortness of breath; Heartbeat is racing; Fever is 99.1 to 102.9 °F; Soreness of joint/feeling soreness in her joint; Pain at injection site of vaccine; Headache; Chills; Loss of appetite/does not have an appetite to eat; Feeling tired, tired all over her body; Not feeling well; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A 52-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ER2613; Expiration Date: 31Jul2021), via an unspecified route of administration, administered in Arm Right on 30Mar2021 (at the age of 52-year-old) as dose 2, single for covid-19 immunization. Medical history included asthma, COPD, Acid reflux, narcolepsy, seizures and sinus tachycardia from an unknown date and unknown if ongoing. Concomitant medications included metoprolol (formulation: Tablet, strength: 25 mg) taken for sinus tachycardia and Multivitamin taken for an unspecified indication start and stop dates were not reported. Historical vaccine included that patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number was not reported), via an unspecified route of administration on 09Mar2021 (at the age of 52-year-old) as dose 1, single for covid-19 immunization. The patient reported after having second dose she had shortness of breath, and fever, the fever was 99.1 to 102.9 fahrenheit and she had also experienced periodic heartbreaking and her heartbeat was racing and she was feeling soreness in her joint, she was feeling tired, tired all over her body and she also experience chills, headache, pain at injection site of vaccine she was not nauseated but she does not have an appetite to eat. She added, she had other medications that she normally takes but she had not taken them since she was not feeling well, she do not want to risk more issues. She takes medication for asthma, COPD, seizures, reflux, and narcolepsy. She had not taken any meds today; she took meds all yesterday, so she stopped all meds (unspecified Medications) today so that she do not have any interaction. Patient was drinking coffee and staying in bed. The patient underwent lab tests and procedures which included blood test 2 weeks ago, on an unspecified date in Feb2021 before the COVID shot and COVID test done in last month on an unspecified date in Feb2021. The outcome of all events was unknown.  No follow-up attempts are possible. No further information is expected.
Pt. states that after receiving the 2nd dose of Moderna 09/16/2021, started experiencing symptoms of increase in pain due to chronic migraines, light sensitivity, nausea, fatigue, vomiting, Vertigo, Photophobia, frequent falls unbalanced, thrush, weight loss, muscle aches, and back pain. Primary visit 09/2021 prescribed Prednisone with no changes. Emergency Room visit 10/07/2021 (denied Medical Care), Vision examined = Normal (recommendation continue use of previous prescription). Still experiencing symptoms. Extreme loss of appetite, weight loss associated. 11/16/2021 scheduled for Stomach scope/colonoscopy, 11/29/2021 Primary appt. full results.
Patient said she passed out 3 times the next day, has felt dizzy all week, and her blood sugar has been elevated.
The vaccine expired past the 3-day recommendation. At this time there have not been any s/s of any adverse event
PT presented to medical facility s/p "fainting." He was sent to hospital & admitted with a Pulmonary Embolism, treated,  and released the next day, & placed on eloquis,
A week or two after the second shot I started filling pain in middle of the chest. It was getting better if I was taking an Aspirin. The pain disappeared two weeks later. The pain appeared again three days ago after I swam for 5-10 minutes at the moment I got tired. Now I have the pain occurring from time to time...
Fatigue, fever, chills, nausea, and body aches 12 hours after the administration of the vaccine. These symptoms lasted 3 days. Rash with blisters all over the body (similar to chickenpox) 36 hours after the administration of the vaccine. This symptom is ongoing.
This spontaneous report as received from a pharmacist refers to a 57 year old male patient. Patients historical condition reported as Hepatitis C. Patient had no known drug allergies. On 24-JAN-2014, the patient was vaccinated with PNEUMOVAX23 (lot # J010332, expiry date: 14-JAN-2015) in the outer aspect of the left arm. Concomitant therapies included tdap (manufacturer unknown). The redness and swelling at site of injection had extended from the axilla to elbow and slightly beyond. On 26-JAN-2014, the patient was hospitalized for an over night stay. On 26-JAN-2014, patient was diagnosed with cellulitis (hospitalization). The patient was treated with Clindamycin and SEPTRA DS for an unspecified time. On 27-JAN-2014, the patient was discharged from hospital. He was currently prescribed an unspecified blood pressure medication. The outcome of event cellulitis was unknown. The reporter causality for the event cellulitis with the therapy of PNEUMOVAX23 was reported as to be related. This case is linked to several reports via same reporter link. Additional information has been requested.
Pt dev flu-like resp sxs more than a wk /p being admin Flu vax. Pt expired, cause unknown, 16OCT90.  F/U 05NOV90:  PT WAS TERMINALLY ILL W/ MALIGNANT BRAIN TUMOR, DEV RESP COMPLICATIONS, SHALLOW BREATHING, T 101.8 & CONGESTION 12 D P/ VAX
Sharp 1-2 second pain medial Rt forearm. Sl superficial ecchymosis where pt pinched self at pain site. NT to palp, FROM, no nodule.
This is a spontaneous report from a contactable nurse (patient). A patient, of unspecified age and gender, received the third dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# unknown, expiry date: unknown), via unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunisation. Historical vaccine included the first and second dose of BNT162B2, via unspecified route of administration on Dec 18, 2020 and Jan 15, 2021, both single dose, for COVID-19 immunisation. Patient suffered from chronic fatigue syndrome for 8 years (thought to be caused by herpetic seni zoster/systemic shingles virus). Concomitant medications not reported. After the first dose, patient noticed an unusual increase in energy level. After second dose, patient was off of the antiviral medication (Valtrex), which was taken for 9 months and was symptom free. Patient had an episode three weeks ago with a sinus infection/shingles attack (began steroids and antiviral medications). Patient still felt extremely tired but pain-free, and took booster dose of COVID-19 vaccine. In approximately 4 hours, patient felt a tingling sensation in lymph nodes in groin, breasts and neck and then felt a surge of energy (much like when steroids begin to reduce inflammation). Patient would like to know if any other CFS patients have had the same response to the vaccine. Patient would like to know more about how and why this worked for symptoms. Patient felt better than had felt in 8 years. Any feedback would be appreciated. The outcome of events unknown. The lot number for BNT162B2 not provided and will be requested during follow-up.
This spontaneous report as received from a doctor of pharmacy refers to an 82 years old female patient with a previous history if cancer approximately six years ago, who on 11-JUL-2012, was vaccinated subcutaneously on her right arm with a 0.65 ml dose of ZOSTAVAX (lot number 0364AE, Exp. Date 16-MAR-2013). No other co-suspects were reported. No concomitant medications were reported. The pharmacy stated that patient's daughter called to the pharmacy today, on 30-JUL-2012, to let him know that her mother had been seen by the physician and had shingles. The pharmacist stated that he did not know which physician the patient saw. No treatment information was reported. At the time of the report, the patient had not recovered, had shingles. The relatedness for patient had shingles was unknown for ZOSTAVAX. Additional information has been requested.
Patient was given the Pediatric dose of the booster for 5-11 instead of 12+.
Moderna Covid-19 Vaccine EUA After receiving the first vaccine, started making gasping noises at night, lethargy, fit bit would not register sleep at night, some breathing issues during waking hours. HR observed to decrease to under 40 over the last week of his life.  5 days after 2nd vaccine had extreme fatigue, nightmares, forgot to take regular meds in the morning, 6 days after he woke up very confused and had nightmares and 7 days after vaccination woke up late, exhausted, with shortness of breath all day and refused to go to ER.  Went to bed early and died in the night with his CPAP machine on.
Information has been received from a registered nurse concerning a 9 year old male, with no medical history or allergies who on 07-MAY-2007 at 14:30 PM was vaccinated with a second SC dose of varicella virus vaccine live (Oka/Merck) (lot number 656259/1509F). There was no illness at the time of vaccination. It was report that a few hours after receiving the vaccine injection the patient developed redness, warmth, and swelling at the injection site. No treatment was recommended. The symptoms had persisted and were not resolved as of 9-May-2007. No laboratory studies were performed. Unspecified medical attention was sought. No product quality complaint was involved. Additional information was received from the nurse who reported that in the AM of 08-MAY-07, the patient had a red, swollen, painful arm that was hot to the touch. The patient was afebrile. It was reported that the patient recovered on 10-MAY-07. The patient had no adverse events following prior vaccination. Follow up information was received from the nurse who reported that the reactions were self limiting and went away 72 hours later. No other visits or labs were required. No further information is expected.
Excessive bleeding from the vaginal area and what looks like a large skin looking/mucus looking shedding happening.
5:00 pm. Became very cold. Started shivering uncontrollably. Went to bed. Couldn't get warm. Shivered 4 hours. Temp was 99.5. Became nauseous. Gagged and threw up a small amount. Lasted 4 hours. Ok in AM.
The pt experienced dizziness and headache after 3rd dose and a headache after the 4th dose.
Pt vaccinated w/1st dose of vax developed h/a, myalgia, fatigue & low grade fever;
Grimacing, rapid eye twitching/blinking on right side of face along with lip smacking, and other oral gestures. Also spasm-like movements on right side of arms, hands and legs. Symptoms occur throughout different time frames at times exasperated by TV viewing or a task that requires extra focusing.
9:00 p.m. developed dull headache, chills, muscle aches, nauseated, got worse on Wed 3/26/08. Noted site getting worse, and nausea since then. Temp 100.4. Today temp 101.4, c/o headache, nausea. Site small redness at injection site.